The Taste Mood Diagnostic Study BRSv2

  • Research type

    Research Study

  • Full title

    Using a diagnostic taste test as a surrogate biomarker to predict drug effectiveness in patients with depression (MDD).

  • IRAS ID

    286188

  • Contact name

    David S K Adams

  • Contact email

    davidadams@ranvierhealth.com

  • Sponsor organisation

    Ranvier Health Ltd

  • Clinicaltrials.gov Identifier

    NCT03645447

  • Duration of Study in the UK

    1 years, 6 months, 1 days

  • Research summary

    Research shows a clear link between taste sensitivity and depression. This relates to chemistry shared by the tongue and the brain.

    Our aim is to recruit participants with newly diagnosed major depressive disorder to test the hypothesis that improvement in taste acuity seen within hours of taking a first antidepressant occurs in depressed participants likely to respond to pharmaceutical treatment. We wish to establish what degree of taste threshold change indicates a likely diagnosis of depression so we can generate a diagnostic algorithm and develop a device to aid diagnosis of depression.

    The taste test uses different concentrations of common food flavour solutions, such as sweet, salt, bitter and sour presented in pseudo-random order guided by a taste-testing algorithm. The antidepressant prescribed in the normal way by the patient's GP is used to assess changes in taste sensitivity before and 2-3 hours after ingestion. Validated questionnaires are used to assess mood before antidepressant treatment is begun and following a month of treatment.
    The planned work consists of two paired studies:
    1. A study using the patient's prescribed antidepressant as a probe, with the objective of testing our hypothesis and generating a robust diagnostic algorithm.
    2. An ancillary study, with the first 30 depressed participants, to validate coding of a testing algorithm on a tablet. The algorithm guides the sequential presentation of taste solutions. These first participants will be tested first by use of the testing algorithm as described by a flow chart presented on paper, and then by use of the coded algorithm presented on a tablet.
    Across each of these studies, patients will be followed up with repeat questionnaires after 4-6 weeks of treatment and an optional further taste test. Patients will be asked to complete a feedback questionnaire about their user experience and satisfaction with treatment.

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    21/YH/0051

  • Date of REC Opinion

    27 Apr 2021

  • REC opinion

    Further Information Favourable Opinion